Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases.
The principal finding from this study was the recognition that the α-adrenergic antagonist, phenoxybenzamine, possesses histone deacetylase inhibitory activity. Phenoxybenzamine is approved by the United States Food and Drug Administration for the treatment of hypertensive crises associated with tum...
Saved in: